A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer

NCT00191347 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: pemetrexed
DRUG: gemcitabine

Sponsor

Eli Lilly and Company